Intrinsic Value of S&P & Nasdaq Contact Us

Teligent, Inc. TLGTQ OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
25/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Teligent, Inc. (TLGTQ) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 24/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
25/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — TLGTQ

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-14.67
Book Value / Share$0.00
Revenue / Share$5.45
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2011 $-0.76 $7.81M $-3.01M -38.5%
2012 $-0.99 $8.56M $-3.93M -45.9%
2013 $-0.02 $18.22M $-84K -0.5%
2014 $0.82 $33.74M $5.25M 15.6%
2015 $0.99 $44.25M $6.67M 15.1%
2016 $-2.26 $66.88M $-11.99M -17.9%
2017 $-2.85 $67.25M $-15.19M -22.6%
2018 $-6.77 $65.87M $-36.26M -55%
2019 $-4.67 $65.9M $-25.12M -38.1%
2020 $-14.67 $45.31M $-122.02M -269.3%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message